The Development Of Better Biotech Enzymes
Links shared publicly online about this topic.
- 437total visits
The Development Of Better Biotech Enzymes
View full resource at medicalnewstoday.com
Tags: Protein, Pharma, Biotech, Science
Most Recently Shared on March 15, 2011 at 11:05 pm By:
The Development Of Better Biotech Enzymes http://mnt.to/3ShH #biology
Also Shared By:
Insight: Antidepressants give drugmakers the blues | Reuters
reuters.com — “LONDON (Reuters) - The development of a novel antidepressant ground to a halt this week when researchers found it did not make patients feel any better than the pills they were already taking.The drug” View full resource at reuters.com
Most Recently Shared on March 23, 2012 at 1:54 pm By:
Richard G. Lanzara Health Professional
Insight: Antidepressants give drugmakers the blues http://t.co/dGMJXLeJ via @reuters #pharma #biotech #medicine
Bend Research, in nod to Pfizer, eyes biotherapeutics drug delivery - FierceDrugDelivery
fiercedrugdelivery.com — “Bend Research plans to expand its drug delivery and manufacturing technology know-how into developing better biotherapeutics and vaccines. And it looks like we have Pfizer ($PFE) to thank for it. The Read more >>” View full resource at fiercedrugdelivery.com
Most Recently Shared on March 21, 2012 at 12:29 pm By:
Bend Research, in nod to Pfizer, eyes biotherapeutics drug delivery http://t.co/FgGYWXAs $PFE #biotech
UPDATED: Amgen scoops up Micromet tumor-fighting pipeline for $1.2B - FierceBiotech
fiercebiotech.com — “Not to be left out of the M&A rush, Amgen said this morning that it will buy German/U.S. cancer drug developer Micromet ($MITI) for $1.16 billion in cash. At $11 a share, the deal gives its Read more...” View full resource at fiercebiotech.com
Most Recently Shared on January 26, 2012 at 1:49 pm By:
Luke Timmerman Health Communicator
A digestable buy for AMGN http://t.co/wf17Py7F RT @JohnCFierce: Amgen scoops up Micromet cancer drug pipeline for $1.2B http://t.co/bpeGk1ac
Plexxikon's Hirth offers a "small" solution to Big Pharma's R&D woes - FierceBiotech
fiercebiotech.com — “Over the years Peter Hirth has gradually perfected his smaller-is-better approach to developing new drugs. As president of Sugen he played a big role in creating Sutent before selling the company. Read more...” View full resource at fiercebiotech.com
Most Recently Shared on September 7, 2011 at 2:07 pm By:
Plexxikon's Hirth offers a "small" solution to Big Pharma's R&D woes http://t.co/L21rLty
Biotech, food and the future
eurekalert.org — “Better Living Through Science: A discussion on plant biotechnology -- how biotech crops could feed the world?s growing population and how the development of gluten-free wheat might bring hope to Celiac disease sufferers ?-- at the German Center for Research and Innovation on Sept. 13, 2011.” View full resource at eurekalert.org
Most Recently Shared on August 31, 2011 at 12:46 am By:
Dr. M Salim Ismail MD Physician, Doctor, CAM, and Integrative Physician
Biotech, food and the future - (German Center for Research and Innovation) Better Living Through Science: A discussi... http://t.co/9TAxqrw
Enobia Pharma Raises US $40 Million - PR Newswire - sacbee.com
sacbee.com — “/PRNewswire/ -- Enobia Pharma Inc., a clinical stage biotech company focused on developing novel therapeutics for serious bone disorders, today announced that it has raised US $40 million through the private placement of approximately 13,724,000 shares of its common stock to new pharmaceutical and financial investors. The proceeds will be used to fund the ongoing development of ENB-0040, Enobia's enzyme replacement therapy (ERT) for hypophosphatasia, a rare and potentially life threatening” View full resource at sacbee.com
Most Recently Shared on August 10, 2011 at 12:57 am By:
Enobia raises $40M for ENB-0040, an enzyme replacement therapy for hypophosphatasia. http://bit.ly/oSLI8R
Triangle agricultural biotech firm to build plant in China :: Editor's Blog at WRAL Tech Wire
wraltechwire.com — “BioResource International, which develops and produces enzymes and additives for animal feed, will own 40 percent of the $10 million plant.” View full resource at wraltechwire.com
Most Recently Shared on April 18, 2011 at 1:05 pm By:
ScienceintheTriangle Science Enthusiast
Triangle agricultural biotech company plans to build production plant in China. (WRALTechwire) http://bit.ly/g6DjjI #SITT
The development of better biotech enzymes
sciencedaily.com — “Enzymes are proteins that speed up chemical reactions, such as laundry detergent digesting protein stains, which are otherwise very difficult to remove. Scientists have now demonstrated a fundamental principle in changing the activity of enzymes by means of protein engineering.” View full resource at sciencedaily.com
Most Recently Shared on March 16, 2011 at 2:11 am By:
The development of better biotech enzymes: Enzymes are proteins that speed up chemical reactions, such as laundr... http://bit.ly/fMnmjT
An Obscure Enzyme May Help Predict Which Cancers Will Spread : Shots - Health Blog : NPR
npr.org — “Researchers at the National Institute for Child Health and Human Development say they have a found a way to better predict which cancers will spread within a few years. The test, though intriguing, remains experimental.” View full resource at npr.org
Most Recently Shared on February 4, 2011 at 2:01 pm By:
Thomas Loarie, Jr Health Advocate
NPR: An Obscure Enzyme May Help Predict Which Cancers Will Spread-More at http://n.pr/fTxgpo
An Obscure Enzyme May Help Predict Which Cancers Will Spread : Shots - Health News Blog : NPR
npr.org — “Researchers at the National Institute for Child Health and Human Development say they have a found a way to better predict which cancers will spread within a few years. The test, though intriguing, remains experimental.” View full resource at npr.org
Most Recently Shared on February 1, 2011 at 6:42 pm By:
An Obscure Enzyme May Help Predict Which Cancers Will Spread http://n.pr/dTFtnI
Lundbeck forges CNS pact with Zenobia, Vernalis - FierceBiotech
fiercebiotech.com — “Denmark's Lundbeck has forged development pacts with Vernalis as well as Zenobia Therapeutics on an brain enzyme inhibition program designed to target CNS (central nervous system) ailments such as Read more...” View full resource at fiercebiotech.com
Most Recently Shared on December 16, 2010 at 4:48 pm By:
Lundbeck forges CNS pact with Zenobia, Vernalis. http://bit.ly/et1grO
Developers zero in on the new 'bio-better' strategy - FierceBiotech
fiercebiotech.com — “The Wall Street Journal's venture blog focuses on three upstart biotechs plotting to push programs on new "bio-betters," essentially second-gen biologics that can pull the market rug out from under Read more...” View full resource at fiercebiotech.com
Most Recently Shared on August 11, 2010 at 1:15 pm By:
Developers zero in on the new 'bio-better' strategy. http://bit.ly/9ORHym
Merck trumpets a global research initiative to speed cancer drugs - FierceBiotech
fiercebiotech.com — “Merck (NYSE: MRK) has pieced together an international network of cancer research centers that will collaborate with the Big Pharma company on new and better ways to speed the development of cancer... Read more...” View full resource at fiercebiotech.com
Most Recently Shared on June 4, 2010 at 12:30 pm By:
John Carroll Health Communicator
Merck is touting a global initiative on cancer trials. Sounds good, but will it work? http://bit.ly/cq40IX
Newron shares crash after neuropathic pain drug flunks trial - FierceBiotech
fiercebiotech.com — “Shares of Newron Pharmaceuticals (SW: NWRN) took a pummeling this morning after the developer revealed that its neuropathic low back pain drug ralfinamide failed to perform any better than a placebo... Read more...” View full resource at fiercebiotech.com
Most Recently Shared on May 6, 2010 at 11:32 am By:
John Carroll Health Communicator
Newron shares took a beating- down 55%-after neuropathic pain drug flunked a trial. http://bit.ly/dn4NBo
Advertisement
MNT Pharma News
@mnt_pharma
The Development Of Better Biotech Enzymes http://mnt.to/3ShH #pharma #pharmaceutical
1 year ago...